Istituti Clinici Scientifici Maugeri Spa – Società Benefit

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Heart Failure Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Chronic Obstructive Pulmonary Disease Medicine & Life Sciences
Rehabilitation Medicine & Life Sciences
Exercise Medicine & Life Sciences
Italy Medicine & Life Sciences
Lung Medicine & Life Sciences
Muscles Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Lul Abdi Ali

Lul Abdi Ali

Person: Academic

20022018
No photo of Domenico Acanfora

Domenico Acanfora

Person: Academic

20162018
No photo of Maria Pia Achilli

Maria Pia Achilli

Person: Academic

20182018

Projects 2018 2018

MAUGERI - MEDICINA CLINICA-SPECIALISTICA

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

MAUGERI - CARDIOANGIOLOGIA RIABILITATIVA

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

MAUGERI - MEDICINA DEL LAVORO, TOSSICOLOGIA E RISCHI AMBIENTALI

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

Research Output 1951 2019

A multicenter randomized controlled trial on the upper limb robotic rehabilitation in subacute stroke using a set of robotic and sensor-based devices: Feasibility of the InTeReSt study

The FDG Robotic Rehabilitation Group, Aprile, I., Germanotta, M., Cruciani, A., Loreti, S., Pecchioli, C., Montesano, A., Galeri, S., Cecchi, F., Diverio, M., Falsini, C., Speranza, G., Langone, E. & Padua, L., Jan 1 2019, Biosystems and Biorobotics. Springer International Publishing AG, p. 508-512 5 p. (Biosystems and Biorobotics; vol. 21).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Patient rehabilitation
Robotics
Sensors
Health

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

Gamucci, T., Pizzuti, L., Natoli, C., Mentuccia, L., Sperduti, I., Barba, M., Sergi, D., Iezzi, L., Maugeri-Saccà, M., Vaccaro, A., Magnolfi, E., Gelibter, A., Barchiesi, G., Magri, V., D’Onofrio, L., Cassano, A., Rossi, E., Botticelli, A., Moscetti, L., Omarini, C. & 29 othersFabbri, M. A., Scinto, A. F., Corsi, D., Carbognin, L., Mazzotta, M., Bria, E., Foglietta, J., Samaritani, R., Garufi, C., Mariani, L., Barni, S., Mirabelli, R., Sarmiento, R., Graziano, V., Santini, D., Marchetti, P., Tonini, G., Di Lauro, L., Sanguineti, G., Paoletti, G., Tomao, S., De Maria, R., Veltri, E., Paris, I., Giotta, F., Latorre, A., Giordano, A., Ciliberto, G. & Vici, P., Feb 1 2019, In : Cancer Biology and Therapy. 20, 2, p. 192-200 9 p.

Research output: Contribution to journal › Article

Taxoids
Observational Studies
Retrospective Studies
Breast Neoplasms
Maintenance
1 Citation (Scopus)

Attempting to remedy sub-optimal medication adherence in haemophilia: The rationale for repeated ultrasound visualisations of the patient's joint status

Di Minno, A., Spadarella, G., Nardone, A., Mormile, M., Ventre, I., Morfini, M. & Di Minno, G., Jan 1 2019, In : Blood Reviews. 33, p. 106-116 11 p.

Research output: Contribution to journal › Review article

Medication Adherence
Hemophilia A
Joints
Joint Diseases
Factor VIII